Subscribe to RSS
DOI: 10.1055/s-2004-834821
Synthesis of DNA-Interactive Pyrrolo[2,1-c][1,4]benzodiazepines by Employing Polymer-Supported Reagents: Preparation of DC-81
Publication History
Publication Date:
20 October 2004 (online)

Abstract
Polymer-supported reagents have been utilized for the generation of combinatorial library of substituted pyrrolo[2,1-c][1,4]benzodiazepine derivatives that provides a clean and efficient preparation and does not require conventional purification techniques like chromatography. This methodology involves intra molecular aza-Wittig reaction and has been extended for the synthesis of the natural product DC-81 in good overall yields.
Key words
polymer-supported reagents - combinatorial library - pyrrolo[2,1-c][1,4] benzodiazepines
-
1a
Ley SV.Baxendale IR.Bream RN.Jackson PS.Leach AG.Longbottom DA.Nesi M.Scott JS.Storer RI.Taylor SG. J. Chem. Soc., Perkin Trans. 1 2000, 3815 -
1b
Ley SV.Baxendale IR.Brusotti G.Caldarelli M.Massi A.Nesi M. Il Farmaco 2002, 57: 321 -
1c
Baxendale IR.Ley SV.Piutti C. Angew. Chem. Int. Ed. 2002, 41: 2194 -
1d
Baxendale IR.Lee A.-L.Ley SV. Synlett 2001, 9: 1482 -
1e
Caldarelli M.Habermann J.Ley SV. J. Chem. Soc., Perkin Trans. 1 1999, 107 - 2
Thurston DE. In Molecular Aspects of Anticancer Drug-DNA InteractionsNeidle S.Waring MJ. Macmillan; London: 1993. p.54 - 3
Petrusek RL.Uhlenhopp EL.Duteau N.Hurley LH. J. Biol. Chem. 1982, 257: 6207 -
4a
Thurston DE.Bose DS. Chem. Rev. 1994, 94: 433 -
4b
Kamal A.Rao MV.Laxman N.Ramesh G.Reddy GSK. Curr. Med. Chem.: Anti-Cancer Agents 2002, 2: 215 -
5a
Gregson SJ.Howard PW.Hartley JA.Brooks AA.Adams LJ.Jenkins TC.Kelland LR.Thurston DE. J. Med. Chem. 2001, 44: 737 -
5b
Gregson SJ.Howard PW.Gullick DR.Hamaguchi A.Corcoran KE.Brooks NA.Hartley JA.Jenkins TC.Patel S.Guille MJ.Thruston DE. J. Med Chem. 2004, 47: 1161 -
6a
Kamal A.Ramesh G.Ramulu P.Srinivas O.Rehana T.Sheelu G. Bioorg. Med. Chem. Lett. 2003, 13: 3451 -
6b
Kamal A.Ramulu P.Srinivas O.Ramesh G. Bioorg. Med. Chem. Lett. 2003, 13: 3517 -
6c
Kamal A.Srinivas O.Ramulu P.Ramesh G.Kumar PP. Bioorg. Med. Chem. Lett. 2003, 13: 3577 -
6d
Kamal A.Ramesh G.Srinivas O.Ramulu P. Bioorg. Med. Chem. Lett. 2004, 14: 471 -
6e
Kamal A.Reddy PSMM.Reddy DR. Bioorg. Med. Chem. Lett. 2004, 14: 2669 -
6f
Kamal A.Reddy KL.Reddy GSK.Reddy BSN. Tetrahedron Lett. 2004, 45: 3499 -
7a
Kamal A.Reddy PSMM.Reddy DR. Tetrahedron Lett. 2002, 43: 6629 -
7b
Kamal A.Laxman E.Reddy PSMM. Tetrahedron Lett. 2000, 41: 8631 -
7c
Kamal A.Laxman E.Arifuddin M. Tetrahedron Lett. 2000, 41: 7743 -
7d
Kamal A.Laxman E.Reddy PSMM. Synlett 2000, 1476 -
8a
Kamal A.Reddy GSK.Raghavan S. Bioorg. Med. Chem. Lett. 2001, 11: 387 -
8b
Kamal A.Reddy GSK.Reddy KL. Tetrahedron Lett. 2001, 42: 6969 -
8c
Kamal A.Reddy GSK.Reddy KL.Raghavan S. Tetrahedron Lett. 2002, 43: 2103 -
8d
Kamal A.Reddy KL.Devaiah V.Reddy GSK. Tetrahedron Lett. 2003, 44: 4741 -
8e
Kamal A.Reddy KL.Devaiah V.Shankaraiah N. Synlett 2004, 1841 -
8f
Kamal A.Reddy KL.Devaiah V.Shankaraiah N.Reddy YN. Tetrahedron Lett. 2004, 45: 7667 -
9a
Thurston DE.Bose DS. Chem. Rev. 1994, 94: 433 -
9b
Kamal A.Howard PW.Reddy BSN.Reddy BSP.Thurston DE. Tetrahedron 1997, 53: 3223 -
9c
Kamal A.Rao MV.Reddy BSN. Khim. Getero. Soed. (Chem. Heterocycl. Compd.) 1998, 1588 -
10a
Hu W.-P.Wang J.-J.Lin F.-L.Lin Y.-C.Lin S.-R.Hsu M.-H. J. Org. Chem. 2001, 66: 2881 -
10b
Mori M.Uozumi Y.Kimura M.Ban Y. Tetrahedron 1986, 42: 3793 -
11a
Carbateas PM. inventors; US Patent, 3,732,212. ; Chem. Abstr. 1973, 79, P42570x -
11b
Carbateas PM. inventors; US Patent, 3,763,183. ; Chem. Abstr. 1973, 79, P146567t -
11c
Carbateas PM. inventors; US Patent, 3860600. ; Chem. Abstr. 1975, 83, P58892x -
12a
Joshi DD.Sagar AD.Hilage NP.Salunkhe MM. Ind. J. Chem., Sect. B 1993, 32: 1201 -
12b
Weinshenker NM.Shen CM.Wong JY. Org. Synth., Coll. Vol. VI 1988, 951 -
12c
Wolman Y.Kivity S.Frankel M. J. Chem. Soc., Chem. Commun. 1967, 629 -
12d
Liu Y.Vederas JC. J. Org. Chem. 1996, 61: 7856 -
12e
Grieder A.Thomas AW. Synthesis 2003, 1707 -
12f
Hinzen B.Ley SV. J. Chem. Soc., Perkin Trans. 1 1997, 1907 -
12g
Petrini M.Ballini R.Marcantoni E.Rosini G. Synth. Commun. 1988, 18: 847 - 17
Thurston DE.Murty VS.Langley DR.Jones GB. Synthesis 1990, 81 - 18 inventors; Japanese Patent 58180487. Kyowa Hakko Kogyo, Ltd.;
References
Preparation of Compound 5g: N-Cyclohexylcarbodiimide, N′-methyl polystyrene (0.66 mmol, 1.30 mmol/g) was added to a dry reaction vessel. The 2-azido-4-benzoxy-5-methoxy benzoic acid (4g, 150 mg, 0.50 mmol) in CH2Cl2 (5 mL) was added to the dry resin and the resulting mixture was stirred at r.t. After 5 min, prolinol (34 mg, 0.33 mmol) in CH2Cl2 (2 mL) was added and the stirring continued at r.t. for 12 h. The resin was removed by filtration and washed with CH2Cl2. Evaporation of the filtrate provided 5g in 98% yield. 1H NMR (200 MHz, CDCl3): δ = 1.65-1.90 (3 H, m), 2.15-2.20 (1 H, m), 3.25-3.36 (2 H, m), 3.69-3.86 (2 H, m), 3.84 (3 H, s), 4.28-4.37 (1 H, m), 4.75 (1 H, br s), 5.18 (2 H, s), 6.67 (1 H, s), 6.83 (1 H, s), 7.28-7.46 (5 H, m). MS (EI): m/z = 382 [M+].
14
Preparation of Compound 6g: 6-(Methylsulfinyl)hexa-noyl methyl polystyrene (0.52 mmol, 2.20 mmol/g) was swollen in CH2Cl2 (5 mL) at r.t. for 15 min and then cooled to -50 °C. Oxalyl chloride (0.52 mmol, 66 mg) in CH2Cl2
(1 mL) was added dropwise. After 1 h at that temperature, azido alcohol (5g, 100 mg, 0.26 mmol) in CH2Cl2 (1 mL) was added, and the mixture was stirred for 3 h before the addition of Et3N (0.78 mmol, 79 mg). The mixture was allowed to warm to r.t. and stirred overnight. The resin was removed by filtration and washed with CH2Cl2. The filtrate was washed three times with H2O. The organic phases was dried (Na2SO4) and evaporated to afford 6g in 95% yield. 1H NMR (200 MHz, CDCl3): δ = 2.14-2.24 (2 H, m), 3.35-3.49 (2 H, m), 3.89 (3 H, s), 4.09-4.15 (2 H, m), 4.60-4.65 (1 H, m), 5.14-5.20 (2 H, m), 6.69 (1 H, s), 7.32-7.47 (6 H, m), 9.69 (1 H, d, J = 2.33 Hz). MS (EI): m/z = 380 [M+].
Preparation of Compound 7g: Triphenylphosphine polystyrene (0.9 mmol, 3 mmol/g) was suspended in anhyd CH2Cl2 (10 mL) and the azido aldehyde (6g, 70 mg, 0.18 mmol) was added, the suspension was stirred for 4 h at r.t. The resin was removed by filtration and washed with CH2Cl2. Evaporation of the filtrate to afford 6g in 96% yield. 1H NMR (400 MHz, CDCl3): δ = 2.09-2.26 (2 H, m), 3.38-3.80 (5 H, m), 3.87 (3 H, s), 4.98-5.15 (2 H, m), 6.74 (1 H, s), 7.08-7.42 (6 H, m), 7.50 (1 H, d, J = 2.97 Hz). MS (EI): m/z = 336 [M+].
16
Preparation of Compound 8: To a solution of compound 7g (50 mg, 0.15 mmol) in absolute EtOH (3 mL) was added 10% Pd/C (75 mg) under nitrogen atmosphere. 1,4-Cyclo-hexadiene (120 mg, 1.50 mmol) was added drop wise to the solution. The resulting solution was stirred at r.t. for 2.5 h. The reaction mixture was filtered and evaporated to afford 8 in 91% yield. 1H NMR (400 MHz, CDCl3): δ = 2.01-2.10
(2 H, m), 2.30-2.36 (2 H, m), 3.55-3.61 (1 H, m), 3.70-3.74 (1 H, m), 3.79-3.87 (1 H, m), 3.96 (3 H, s), 6.41 (-OH, br s), 6.90 (1 H, s), 7.52 (1 H, s), 7.67 (1 H, d, J = 4.4 Hz). MS (EI): m/z = 246 [M+]. [α]26
D +296 (c 0.02, CHCl3); lit.
[18]
[α]22
D +135 (c 0.2, CHCl3).